Home›Compare›Elektra Health vs MangoRx

Elektra Health vs MangoRx: Which Is Better?

Head-to-head comparison of Elektra Health and MangoRx based on our independent scoring across trust, value, experience, product range, and reputation — plus real pricing for the treatments they both offer.

Our Verdict

Elektra Health scores higher overall in our independent evaluation (62.7/100 vs 58/100), leading on trust & safety, experience, reputation. MangoRx comes out ahead on value, product range. MangoRx has the lower entry price (from $50/mo vs $149/mo), so the better value depends on which treatment you need.

New York-based menopause clinic combining telemedicine with a board-certified clinician and a 1:1 coach, insurance-first (including NY Medicaid) with $249/$149 cash visits, in 16 states.

Visit Elektra Health
58

MangoRx is the Dallas-based men's health telehealth brand of Nasdaq-listed Mangoceuticals, selling compounded ED, hair-loss and oral semaglutide products alongside injectable and oral (Kyzatrex) testosterone.

Visit MangoRx

Score Breakdown

DimensionElektra HealthMangoRx
Overall Score62.7/100 ✓58/100
Trust & Safety30%76/100 ✓55/100
Value25%55/10062/100 ✓
Experience20%60/100 ✓58/100
Product Range15%50/10066/100 ✓
Reputation10%66/100 ✓45/100

At a Glance

Founded20192021
HeadquartersNew York, NYDallas, TX
Publicly tradedNoYes (MGRX)
Treatment categories25
Treatments listed35
Starting price$149/mo$50/mo

Pricing Where They Compete

Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.

CategoryElektra HealthMangoRx
Hormone Therapy—$99
Injectable TRT (testosterone cypionate)

Elektra Health

+Prescribes only FDA-approved therapies, with named, credentialed clinicians (most Menopause Society-certified)
+Each patient is paired with both a clinician and a 1:1 coach, plus an education library and community events
+Accepts commercial insurance and several New York Medicaid plans; partnered with Oscar Health on a menopause-focused ACA plan
−Clinical care is limited to 16 states
−Cash visits are expensive ($249 initial, $149 per 15-minute follow-up), and medications are billed separately at the patient's pharmacy
−$50 fee for cancellations inside 24 hours; a reviewer reports being billed for a consult advertised as free
Read the full Elektra Health review →

MangoRx

+Injectable TRT program priced at $99/month with doctor visits, lab work and medication included (per February 2026 company release and current site listing)
+Offers a branded FDA-approved oral testosterone option (Kyzatrex-based 'Prime') alongside compounded injectable TRT, which few small men's-health platforms carry
+Public-company SEC disclosures make ownership, pharmacy relationships and finances unusually visible for a brand this size
−Going-concern risk: $228,688 cash on hand at June 30, 2026 against a six-month net loss of $4.7M, per its Q2 2026 10-Q
−Compounded products are filled by Epiq Scripts, a pharmacy majority-owned (52%) by the CEO, a related-party arrangement
−Very small patient base: Q2 2026 revenue of $68,757, down 59% year over year, and only 18 Trustpilot reviews
Read the full MangoRx review →

Elektra Health vs MangoRx — FAQ

Is Elektra Health better than MangoRx?

▾

Elektra Health scores higher overall in our independent evaluation (62.7/100 vs 58/100), leading on trust & safety, experience, reputation. MangoRx comes out ahead on value, product range. MangoRx has the lower entry price (from $50/mo vs $149/mo), so the better value depends on which treatment you need.

Is Elektra Health or MangoRx cheaper?

▾

MangoRx has the lower starting price (from $50/mo vs $149/mo for Elektra Health). Starting prices are for the cheapest treatment each offers — compare the specific treatment you need, and check what each price includes.

What do Elektra Health and MangoRx both offer?

▾

Both platforms treat Hormone Therapy. Elektra Health covers 2 treatment categories total and MangoRx covers 5.

Still deciding?